General Information
Daiichi HTN 301
A Randomized, Double-Blind, Parallel Group Study Evaluating the Efficacy of Safety of Co-Administration of a Triple Combination Therapy of Olmesartan Medoximil, Amlodipine Besylate and Hydrochlorothiazide in Subjects with Hypertension
| Protocol | CS8635-A-U301 |
|---|---|
| Identifier | CS8635-A-U301 |
| UID | 35243ea2-b51a-4fa5-a2b7-808c803c8b3d |
| Status | Done - Archived |
| Phase | 3 |
| Category | Hypertension / Adult |
| Launch Year | 2008 |
| NCT Number | - |
| Created | 2010-05-21 16:00 |
| Last Updated | 2010-05-21 16:00 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2008-11-13 | No |
| Enrollment Open | 2008-07-01 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | No | |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2010-03-09 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Zolnouni, Parvaneh | PZolnouni | No |
| Recruiter | - | No | |
| Coordinator | Villegas, Claudia | CVillegas | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Daiichi Sankyo Pharma Development |
|---|---|
| Division | Daiichi Sankyo Pharma Development |
| Team | Daiichi Sankyo Pharma Development |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
